Serum type-2 macro-creatine kinase isoenzyme is not a useful marker of severe liver diseases or neoplasia
- 1 December 1990
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 23 (6) , 523-527
- https://doi.org/10.1016/0009-9120(90)80043-i
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- The Serum Gamma-glutamyltransferase Isoenzyme System and its Diagnostic Role in Hepatobiliary DiseasesPublished by Springer Nature ,1989
- Electrophoretic behavior and partial characterization of disease‐associated serum forms of gammaglutamyltransferaseElectrophoresis, 1989
- Diagnostic efficiency in discriminating liver malignancies from cirrhosis by serum gamma-glutamyltransferase isoformsClinica Chimica Acta; International Journal of Clinical Chemistry, 1988
- Source of elevated serum mitochondrial creatine kinase activity in patients with malignancyClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- Creatine Kinase and its Isoenzymes in Neoplastic DiseaseCRC Critical Reviews in Clinical Laboratory Sciences, 1986
- Mitochondrial creatine kinase as a tumor-associated markerClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Prognosis of Primary Hepatocellular CarcinomaHepatology, 1984
- Determination of pseudouridine and other nucleosides in human blood serum by high-performance liquid chromatographyAnalytical Biochemistry, 1983
- Improved electrophoretic separation of creatine kinase isoenzymes.Clinical Chemistry, 1980
- Serum alphafetoprotein in hepatocellular carcinomaCancer, 1977